Pervasive Sign Epistasis between Conjugative Plasmids and Drug-Resistance Chromosomal Mutations
Open Access
- 28 July 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 7 (7) , e1002181
Abstract
Multidrug-resistant bacteria arise mostly by the accumulation of plasmids and chromosomal mutations. Typically, these resistant determinants are costly to the bacterial cell. Yet, recently, it has been found that, in Escherichia coli bacterial cells, a mutation conferring resistance to an antibiotic can be advantageous to the bacterial cell if another antibiotic-resistance mutation is already present, a phenomenon called sign epistasis. Here we study the interaction between antibiotic-resistance chromosomal mutations and conjugative (i.e., self-transmissible) plasmids and find many cases of sign epistasis (40%)—including one of reciprocal sign epistasis where the strain carrying both resistance determinants is fitter than the two strains carrying only one of the determinants. This implies that the acquisition of an additional resistance plasmid or of a resistance mutation often increases the fitness of a bacterial strain already resistant to antibiotics. We further show that there is an overall antagonistic interaction between mutations and plasmids (52%). These results further complicate expectations of resistance reversal by interdiction of antibiotic use. Bacteria can become resistant to antibiotics by spontaneous mutation of chromosomal genes or through the acquisition of horizontally mobile genetic elements, mainly conjugative plasmids. Plasmid-borne resistance is widespread among bacterial pathogens. Plasmids generally entail a cost to the host, associated with the replication and maintenance of the genetic element and with the expression of its genes. Therefore, in the absence of antibiotic, both plasmids and resistance mutations are often deleterious and confer a fitness cost to the cell. Here we studied epistatic interactions between five natural conjugative plasmids and ten chromosomal mutations conferring resistance to three types of antibiotics, making a total of 50 different combinations of chromosomal mutations and conjugative plasmids. We show that sometimes plasmids confer an advantage to bacterial strains carrying resistance mutations in their chromosome. This occurs in 32% (16 out of 50) of tested combinations. Furthermore, in 5 out of 50 plasmid-mutations combinations studied (10%), we observed an increased fitness when a plasmid-bearing bacterial cell acquires a drug-resistant mutation. These examples of sign epistasis are highly unexpected. This work explains, at least in part, how multidrug resistance evolved so rapidly.Keywords
This publication has 60 references indexed in Scilit:
- Adaptive landscapes and protein evolutionProceedings of the National Academy of Sciences, 2010
- Prevalent positive epistasis in Escherichia coli and Saccharomyces cerevisiae metabolic networksNature Genetics, 2010
- Inference and Characterization of Horizontally Transferred Gene Families Using Stochastic MappingMolecular Biology and Evolution, 2009
- Conjugative plasmids: vessels of the communal gene poolPhilosophical Transactions of the Royal Society B: Biological Sciences, 2009
- Epistasis — the essential role of gene interactions in the structure and evolution of genetic systemsNature Reviews Genetics, 2008
- Exposing plasmids as the Achilles’ heel of drug-resistant bacteriaCurrent Opinion in Chemical Biology, 2008
- Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteriaBritish Journal of Pharmacology, 2008
- Genomic buffering mitigates the effects of deleterious mutations in bacteriaNature Genetics, 2005
- The evolution of a conjugative plasmid and its ability to increase bacterial fitnessBiology Letters, 2005
- Long-Term Experimental Evolution in Escherichia coli. I. Adaptation and Divergence During 2,000 GenerationsThe American Naturalist, 1991